Yu Kato

USPTO Granted Patents = 4 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 1

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Tsukuba, JP (2016 - 2018)
Tokyo, JP (2023 - 2024)

Company Filing History:

4 out of 527

Eisai R&d Management Co., Ltd.

patents

2 out of 2,405

Merck Sharp + Dohme Corp.

patents

where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...

4 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12083112 - Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer (2024-09-10),

2. 11547705 - Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer (2023-01-10),

3. 9969812 - Anti human Notch4 antibody (2018-05-15),

4. 9527921 - Anti human Notch4 antibody (2016-12-27),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.